Press Releases from Optima insights Pvt Ltd (43 total)
Endometriosis Treatment Market is Expected to Reach $3.43 bn by 2027
The Endometriosis Treatment Market was valued at US $2.64 billion in the year 2019 and is estimated to reach US $3.43 billion by 2027, at a CAGR of 3.36%.
The growth of tissue outside the uterus similar to lining of uterus (endometrium) refers to Endometriosis. Areas of endometrial tissue growth often occur in ovaries, fallopian tubes, peritoneum and outer surfaces of bladder, uterus, intestines, and rectum and rarely spread beyond pelvic…
Inflammatory Bowel Disease (IBD) Treatment Market is Expected to Reach $15.5 bn …
The Inflammatory Bowel Disease (IBD) treatment market share was US$ 11.38 Bn in the year 2018. The market is anticipated to grow at a rate of 3.94%, through the forecast period to reach US$ 15.5 Bn by the year 2027.
Inflammatory Bowel Disease (IBD) usually denotes disorders characterized by the inflammation in the digestive system. Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome are two different disorders that are often confused…
Polycystic Ovarian Syndrome (PCOS) Treatment Market is Expected to Reach $5.59 b …
The Polycystic Ovarian Syndrome (PCOS) Treatment Market was valued at US $3.74 billion in the year 2019 and is estimated to reach US $5.59 billion by 2027, at a CAGR of 5.18%.
Polycystic Ovarian Syndrome (PCOS), also referred to as Stein-Leventhal syndrome is a hormonal disorder characterized by enlarged ovaries and formation of numerous small cysts (fluid-filled sacs) on the outer edges of the ovaries. Symptoms of PCOS include irregular periods,…
Veterinary Vaccines Market is Expected to Reach $13.51 bn by 2027
The Veterinary Vaccines Market was valued at US $7.91 billion in the year 2018 and is estimated to reach US $13.51 billion by 2027, at a CAGR of 6.13%.
Generally, vaccines are effective in preventing infectious diseases. Veterinary vaccines especially reduce the burden of the disease in animals and also helps in preventing several zoonotic diseases also. There are four types of veterinary vaccines available depending on preparation type, they are…
Animal Feed Additives Market is Expected to Reach $47.75 bn by 2026
The Animal Feed Additives Market was valued at US$35.82 billion in the year 2018 and is estimated to reach US$47.75 billion by 2026, at a CAGR of 3.66%.
Feed additives are substances that enhance the nutritional efficiency of animals. The use of additives in veterinary feed is practiced from the early 1960s, especially, antibiotics are an integral part of veterinary health. Besides, several feed additives including probiotics, amino acids, vitamins and…
Rare Disorders Series II (Hypoparathyroidism) Treatment Market is Expected to Re …
The Hypoparathyroidism Treatment Market was valued at US$658.58 million in the year 2018 and is estimated to reach US$1.09 billion by 2026, at a CAGR of 7.57%.
Hypoparathyroidism is classified as a rare endocrine disorder characterized by failure in producing the required amount of parathyroid hormone or the produced hormone cannot participate in biological activities. Generally, the parathyroid hormone regulates calcium and phosphorus in the blood, determines bone cell activity and…
Digital Therapeutics Market is Expected to Reach $11.11 bn by 2026
The Digital Therapeutics Market was valued at US$2.39 billion in the year 2018 and is estimated to reach US$11.11 billion by 2026, at a CAGR of 21.2%.
Digital Therapeutics are evidence-based interventional treatment devices that use software to collect real-time data, assess the condition and provide appropriate treatment to the patients. Specifically, prescription-based digital devices deliver treatment anywhere anytime even through smartphones for several diseases and disorders which include insomnia, sleep…
Alopecia Areata Treatment Market is Expected to Reach $4.46 bn by 2026
The Alopecia Areata Treatment Market was valued at US $ 2.39 billion in the year 2018 and is estimated to reach US $ 4.46 billion by 2026, at a CAGR of 8.11%.
Alopecia Areata is an autoimmune disorder, targeting hair follicles resulting in hair loss usually in patches on scalp, face, beard, eye brows or other areas of body. Focal, totalis and universalis are the three different patterns occuring in…
Head & Neck Cancer Therapeutics Market is Expected to Reach $2.01 bn by 2026
The Head and Neck Cancer Treatment Market was valued at US$1.03 billion in the year 2018 and is estimated to reach US$2.01 billion by 2026, at a CAGR of 8.7%.
Head and neck cancers are generally a group of cancers that affect the squamous cells of mouth, lips, pharynx, larynx, throat, salivary glands and nose. Tobacco and alcohol usage are ascribed as the major risk factors associated with the development of…
Macular Edema Treatment Market is Expected to Reach $4.08 bn by 2026
The Macular edema Treatment Market was valued at US $3.16 billion in the year 2018 and is estimated to reach US $4.08 billion by 2026, at a CAGR of 3.22%.
Macular Edema occurs due to abnormal leakage and accumulation of fluid in the macula from damaged blood vessels adjacent to retina. The symptoms of macular edema include blurry or distorted vision and colors appear as faded or washed out Edema is…
Thyroid Disorders Treatment Market is Expected to Reach $ 2.67 bn by 2026
The Thyroid Disorders Treatment Market was valued at around US$2.1 billion at the end of 2018. The revenue is said to engross over US$2.67 billion by 2026, with a CAGR of 3.52%.
The thyroid gland is one of the glands which influences all the metabolic processes in our entire body through its secretions. Hypothyroidism (less secretion of the thyroid hormone, TSH Releasing Hormone) and Hyperthyroidism (overt secretion of T3 and T4)…
Gaucher's Disease Treatment Market is Expected to Reach $ 1.67 bn by 2026
The Gaucher's Disease Treatment Market was valued at US$1.51 billion in the year 2018 and is estimated to reach US$1.67 billion by 2026, at a CAGR of 1.22%.
Gaucher's Disease (GD), is an autosomal recessive disorder characterized by the accumulation of fatty substances especially in the liver, spleen, lungs, kidney and bone marrow due to mutation of the GBA gene that encodes for the enzyme ?-glucocerebrosidase. GD is more common among…
Cardiac Stents Market is Expected to Reach $15.54 bn by 2026
The Cardiac Stents Market was valued at US $10.01 billion in the year 2018 and is estimated to reach US $15.54 billion by 2026, at a CAGR of 5.65%
Cardiac stent is small, metal mesh tube that expands inside a coronary artery to treat narrowed arteries. The stent may be coated with a drug called a drug-eluting stent. This type of stent may lower the chance of the artery closing back…
Insight report on Global Sports Insoles Market Industry Trends and Forecast 2026
The Sports Insoles Market was valued at US$181.76 million in the year 2018 and is estimated to reach US$380.77 million by 2026, at a CAGR of 9.39%.
Sports insoles are specially designed to enhance comfort for athletes and sportsperson. Sports insoles minimize pain, increase performance, prevent injury, support the arch, improves posture and balance with neutral alignment. Sports insoles are customized by perfect distribution of the pressure zones, propulsion layer cushioning…
Inhalable Drug Delivery Devices Market is Expected to Reach $41.96 bn by 2026
The Inhalable Drug Delivery Devices Market was valued at US$30.43 billion in the year 2018 and is estimated to reach US$41.96 billion by 2026, at a CAGR of 4.1%.
Inhalation route is one of the effective and quicker way of drug administration directly to the lungs, for treating acute and chronic pulmonary disorders such as chronic obstructive pulmonary disorder, asthma, etc. Besides, recent research also suggests that pulmonary route could be…
Bone Block Fixation Sets Market Research Report 2018-2027: by Application, End- …
The Bone Fixation Devices Market was valued at US $7.68 billion in the year 2018 and is estimated to reach US $13.11 billion by 2027, at a CAGR of 6.12%.
Bone Fixation Devices are used to maintain the stability of the fractured bones through immobilization and offering proper alignment during the healing process. There are two types of bone fixation devices, external and internal. Internal Fixation devices include screws (cortical, cancellous),…
Sinusitis Treatment Market Growth Report 2018 by Major Vendors, Manufacturers Re …
The Sinusitis Treatment Market was valued at US $1.9 billion in the year 2018 and is estimated to reach US $3.7 billion by 2026, at a CAGR of 8.68%.
Sinusitis results from inflammation of sinus lining, air cavities within passage of nose usually caused by infection (bacteria, and viruses), chemical, allergies, and autoimmune problems. Symptoms include nasal obstruction, Rhinorrhea (drainage and postnasal drip), loss of sense, smell & taste, discolored nasal…
Peptic Ulcer Drugs Market is Expected to Register Highest CAGR of 2.92% During t …
The Peptic Ulcer Drugs Market was valued at US $4.76 billion in the year 2018 and is estimated to reach US $5.99 billion by 2026, at a CAGR of 2.92%.
Peptic ulcers are ulcers on lining of stomach, lower esophagus, or small intestine causing abdominal discomfort. These are caused due to erosion from stomach acids and inflammation by Helicobacter pylori (H. pylori) infection. The symptoms of peptic ulcers include burning, stomach…
Global Irritable Bowel Syndrome (IBS) Market Size, New Study, Overview, Advances …
The Irritable Bowel Syndrome Market was valued at US$1.47 billion in the year 2018 and is estimated to reach US$3.07 billion by 2026, at a CAGR of 9.66%.
Irritable Bowel Syndrome (IBS) is a debilitating gastrointestinal disorder characterized by Abdominal pain, Bloating, Constipation, and Diarrhea. IBS quintessentially alters the bowel movements that cannot be confirmed by medical tests. Nonetheless, it is the most common disorder reported by patients visiting a gastroenterologist.…
Age-related Macular Degeneration (AMD) Treatment Technology Market to Witness St …
The Age-Related Macular Degeneration Treatment Market was valued at US $6.72 billion in the year 2018 and is estimated to reach US $11.46 billion by 2026, at a CAGR of 6.90%.
Age-related Macular Degeneration is a condition results in blurred or no vision in the center of the visual field due to damage in the retinal macula. There are two types of macular degeneration namely dry macular degeneration and wet macular…
Global Dialysis Devices Market Overview, Technology, Applications, & Market Stat …
The Dialysis Devices Market was valued at US $17.99 billion in the year 2018 and is estimated to reach US $27.88 billion by 2026, at a CAGR of 5.65%
Dialysis is the treatment method for the patients with end-stage renal disease (ESRD) or kidney injury until they get kidney transplant and, for lifetime in case of transplant kidney rejection and lack of kidney donors.
According to the World…
Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non-Allergic Rhinitis T …
The Allergic Rhinitis Treatment Market was valued at US $6.95 billion in the year 2018 and is estimated to reach US $9.66 billion by 2026, at a CAGR of 4.20%.
Allergic Rhinitis is inflammation caused inside the nose by allergen, also called as hay fever. Allergic Rhinitis develops when body’s immune system becomes sensitized and overreacts on exposure to allergens in the environment. It is mostly triggered by outdoor allergens like…
Obesity Treatment Market Around the World Growing at a CAGR of 12.92% Current an …
The Global Obesity Treatment Market was valued at US$5.55 billion in the year 2018 and is estimated to reach US$14.66 billion by 2026, at a CAGR of 12.92%.
Obesity can be denoted as a condition where excessive fat accumulation is seen in the body that leads to associated health risks such as cardio vascular diseases, diabetes, orthopedic disorders, etc. Previously, it was thought that obesity was prevalent only in the high-income…
Global Urinary Stones Treatment Devices Market - Global Industry Analysis 2026
Urinary stones are mainly formed due to the inability of an individual to empty the urinary bladder. Due to urine accumulation, the minerals in the concentrated urine start crystalizing leading to the formation of stones. Depending on the location of the stone development it may be classified as a kidney stone, bladder stone or ureteral stone. These stones are diagnosed using, abdominal X-ray, CT scan, MRI scan, ultrasound, etc. During…
Endoscopes Market Value Share, Supply Demand, share and Value Chain -2026
The Endoscopes Market was valued at US$9.32 billion in the year 2018 and is estimated to reach US$17.9 billion by 2026, with a CAGR of 8.5%.
Endoscopy is a non-surgical or a minimally invasive procedure or that involves the insertion of a long tube known as an endoscope into our body either through mouth or anus for visualization or for conducting a surgical procedure. Surgery can be conducted through a small…
Multiple Myeloma (Treatment) Market sizes and predictions for growth
The Global Multiple Myeloma Treatment Market was valued at US$10.9 billion in the year 2018 and is likely to reach US$17.5 billion by 2026, with a CAGR of 6.1%.
Multiple Myeloma is a type of blood cancer that is characterized by cancer formation in the white blood cells otherwise denoted as the plasma cells. Generally, antibodies are produced by white blood cells for protection against foreign particles. During multiple myeloma, these…
Global Sleep Apnea Devices Market was valued at US$ 5.1 bn in 2018 and is estima …
The Sleep Apnea Devices Market reached US$5.1 billion at the end of 2018 and is set to stride over US$8.83 Billion at the end of 2026, with a CAGR of 7.1%.
With more than one billion people suffering from sleep apnea, it has become one of the major disorders in recent times. Sleep Apnea is a potential sleep disorder characterized by the repeated intermittent block of breathing during sleep for a…
Antibody Production Market is Expected Growth US$23.22 Billion by 2026
The Global Antibody Production Market was valued at US$9.93 billion in the year 2018 and is expected to reach US$23.22 billion by 2026, at a CAGR of 12.29%.
Antibodies are protein molecules resembling the alphabet ‘Y’. They are innately produced by plasma cells as a primary response and also produced by B cells. They are a part of the immune system that protects against toxins, antigens, and pathogens such as bacteria…
Global Cancer Treatment Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
The global cancer treatment market was valued at $95bn in 2016 and is forecast to grow at a strong 7.2.% CAGR between 2016 and…
Global Multiple Sclerosis Therapeutic Market Outlook to 2024
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
Global Multiple Sclerosis (MS) therapeutic market was valued at $19.5bn in 2015, driven by improved diagnostic criteria, greater disease awareness, novel treatment…
Global Hemophilia Treatment Market to 2024
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
Global hemophilia treatment market was valued at $10.2bn in 2015 and is forecast to grow at a modest 5.4% CAGR between 2015 and 2024, culminating…
Lung Cancer Treatment Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
The global lung cancer drugs market was valued at $3.1bn in 2016 and is forecast to grow at a healthy 31.1% CAGR between 2016…
Breast Cancer Treatment Market Outlook to 2022:
Breast Cancer Treatment Market Outlook to 2022: Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
The global breast cancer treatment market was valued at $12.1bn in 2016 and is forecast to grow…
Global Rheumatology Market to 2024
Global rheumatology market was valued at $31bn in 2015 and is forecast to grow at a modest 4.0% CAGR between 2015 and 2024 to reach 2024 global sales of $46bn.
http://optimainsights.org/request-toc/global-rheumatology-market-to-2024
Rheumatology encompasses numerous musculoskeletal and autoimmune diseases that cause systemic manifestations including joint pain, inflammation and destruction. Worldwide, over 470 million people suffer from rheumatologic diseases. Rheumatology represents a significant disease burden with annual costs associated with rheumatologic diseases estimated at…
Cardiac Rhythm Management Market Outlook to 2024
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
Global CRM market was valued at $10bn in 2015, with two main product categories ICD accounted for an estimated $6.0bn (60%) in…
Global Diabetes Devices Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
Our services : http://optimainsights.org/services
There are 415 million people afflicted with diabetes globally in 2015, growing to an estimated 642 million by 2040. Individuals with…
Global Rheumatology Market to 2024
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
Global rheumatology market was valued at $31bn in 2015 and is forecast to grow at a modest 4.0% CAGR between 2015 and 2024…
Global Multiple Sclerosis Therapeutic Market Outlook to 2024
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
Global Multiple Sclerosis (MS) therapeutic market was valued at $19.5bn in 2015, driven by improved diagnostic criteria, greater disease awareness, novel treatment…
Global HCV Market to 2024
HCV market was valued at $12.5bn in 2015 and is forecast to contract 4.1% CAGR between 2015 and 2024, reaching 2024 global sales of $8.2bn. The volume of HCV patients who will be treated over the next several years is expected to decline resulting in market contraction.
The World Health Organization (WHO) estimates that 185 million people globally are infected with Hepatitis C virus (HCV), with 3 to 4 million…
Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment.
Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5…
Global Diabetes Drugs Market to 2024
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
Global diabetes drugs market was valued at $33.5bn in 2015 and is forecast to grow at a strong 7.6% CAGR between 2015 and 2024,…
Global Aesthetic Dermatology Market to 2024
Global aesthetic dermatology market was valued at $6.2bn in 2015 and is forecast to grow at a modest 6.4% CAGR between 2015 and 2024, to reach 2024 global sales of $11.5bn.
Aesthetic dermatology is a subspecialty of medicine intended to enhance one’s appearance. The pursuit of physical beauty has become big business in developed markets and fast catching up among affluent and wealthy individuals in emerging markets. People seem to be…
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn.
PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
…
